BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32108275)

  • 1. The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Heydari K; Shamshirian A; Lotfi-Foroushani P; Aref A; Hedayatizadeh-Omran A; Ahmadi M; Janbabei G; Keyhanian S; Zaboli E; Ghasemzadeh SM; Alizadeh-Navaei R
    Clin Transl Oncol; 2020 Oct; 22(10):1825-1837. PubMed ID: 32108275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
    Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
    Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary malignancies after hematopoietic stem cell transplantation.
    Roziakova L; Bojtarova E; Mistrik M; Mladosievicova B
    Neoplasma; 2011; 58(1):1-8. PubMed ID: 21067259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second Malignancies after Hematopoietic Stem Cell Transplantation.
    Danylesko I; Shimoni A
    Curr Treat Options Oncol; 2018 Feb; 19(2):9. PubMed ID: 29423555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study.
    Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Shen CC; Ku FC; Chen SC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
    Br J Cancer; 2015 Jan; 112(1):177-84. PubMed ID: 25314066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second malignant neoplasms following hematopoietic stem cell transplantation.
    Friedman DL; Leisenring W; Schwartz JL; Deeg HJ
    Int J Hematol; 2004 Apr; 79(3):229-34. PubMed ID: 15168589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.
    Adhikari J; Sharma P; Bhatt VR
    Future Oncol; 2015; 11(23):3175-85. PubMed ID: 26551415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.
    Chen MH; Chang PM; Li WY; Hsiao LT; Hong YC; Liu CY; Gau JP; Liu JH; Chen PM; Chiou TJ; Tzeng CH
    Bone Marrow Transplant; 2011 Apr; 46(4):567-72. PubMed ID: 20622906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of secondary nonhematologic malignancies after allogeneic stem cell transplantation: A nationwide case-control cohort study.
    Park SS; Park SH; Han S
    Int J Cancer; 2022 Oct; 151(7):1024-1032. PubMed ID: 35554932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of metachronous second primary cancer in head and neck cancer survivors: A systematic review and meta-analysis of the literature.
    Hoxhaj I; Hysaj O; Vukovic V; Leoncini E; Amore R; Pastorino R; Boccia S
    Eur J Cancer Care (Engl); 2020 Sep; 29(5):e13255. PubMed ID: 32400912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Nelson RA; Lai LL
    Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
    Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G
    J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.
    Tichelli A; Beohou E; Labopin M; Socié G; Rovó A; Badoglio M; van Biezen A; Bader P; Duarte RF; Basak G; Salooja N;
    JAMA Oncol; 2019 Feb; 5(2):229-235. PubMed ID: 30476975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.
    Burdach S; van Kaick B; Laws HJ; Ahrens S; Haase R; Körholz D; Pape H; Dunst J; Kahn T; Willers R; Engel B; Dirksen U; Kramm C; Nürnberger W; Heyll A; Ladenstein R; Gadner H; Jürgens H; Go el U
    Ann Oncol; 2000 Nov; 11(11):1451-62. PubMed ID: 11142486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis.
    Shimada K; Yokozawa T; Atsuta Y; Kohno A; Maruyama F; Yano K; Taji H; Kitaori K; Goto S; Iida H; Morishima Y; Kodera Y; Naoe T; Morishita Y
    Bone Marrow Transplant; 2005 Jul; 36(2):115-21. PubMed ID: 15908969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary Neoplasms of the Female Lower Genital Tract After Hematopoietic Cell Transplantation.
    Chang HA; Armenian SH; Dellinger TH
    J Natl Compr Canc Netw; 2018 Feb; 16(2):211-218. PubMed ID: 29439180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation".
    Wareham NE; Li Q; Sengeløv H; Da Cunha-Bang C; Gustafsson F; Heilmann C; Perch M; Rasmussen A; Sørensen SS; Mocroft A; Lundgren JD
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):3125-3135. PubMed ID: 31587105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX; Nelson RA; Kim JY; Raz DJ
    Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.